<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8111">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00856843</url>
  </required_header>
  <id_info>
    <org_study_id>BLI800-303</org_study_id>
    <nct_id>NCT00856843</nct_id>
  </id_info>
  <brief_title>BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects</brief_title>
  <official_title>BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Braintree Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Braintree Laboratories</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of BLI800 vs an FDA approved bowel preparation before
      colonoscopic examination in adult subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Efficacy: Percentage of Patients With Successful Preparations Based on a 4 Point Scale</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blinded colonoscopists rated cleansing quality as either Excellent, Good, Fair or Poor. Scores of Excellent or Good were considered Successful preparations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Stool - Cecum</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Stool - Ascending Colon</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Stool - Transverse Colon</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Stool - Descending Colon</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Stool - Sigmoid Colon/Rectum</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Fluid - Cecum</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Fluid - Ascending Colon</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Fluid - Transverse Colon</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Fluid - Descending Colon</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Residual Fluid - Sigmoid Colon/Rectum</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Symptom Scores</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Expected preparation related symptoms of Abdominal Cramping, Abdominal Bloating, Nausea and Overall discomfort were rated by each subject from 1 - 5 (1=none, 2=mild, 3=bothersome, 4=distressing, 5=severely distressing).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Serum Chemistry (mg/dL)</measure>
    <time_frame>up to 15 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Mean changes from Baseline to Post-preparation for the following analytes will be compared between treatment groups: blood urea nitrogen, calcium, creatinine, phosphorus. Baseline lab samples were allowed to be drawn within 15 days of the post-preparation (Visit 2) lab draw.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change in Serum Chemistry (mEq/L)</measure>
    <time_frame>up to 15 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Mean changes from Baseline to Post-preparation for the following analytes will be compared between treatment groups: bicarbonate, chloride, magnesium, potassium, sodium. Baseline lab samples were allowed to be drawn within 15 days of the post-preparation (Visit 2) lab draw.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">136</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Polyethylene glycol 3350 based bowel preparation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polyethylene glycol 3350 based bowel preparation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BLI800</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BLI800</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BLI800</intervention_name>
    <description>Solution for oral administration prior to colonoscopy</description>
    <arm_group_label>BLI800</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polyethylene glycol 3350 based bowel preparation</intervention_name>
    <description>Solution for oral administration prior to colonoscopy</description>
    <arm_group_label>Polyethylene glycol 3350 based bowel preparation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female outpatients who are undergoing colonoscopy for a routinely accepted
             indication.

          2. At least 18 years of age

          3. Otherwise in good health, as determined by physical exam and medical history

          4. If female, and of child-bearing potential, is using an acceptable form of birth
             control

          5. Negative urine pregnancy test at screening, if applicable

          6. In the Investigator's judgment, subject is mentally competent to provide informed
             consent to participate in the study

        Exclusion Criteria:

          1. Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal
             obstruction, gastric retention, bowel perforation, toxic colitis or megacolon.

          2. Subjects who had previous gastrointestinal surgeries.

          3. Subjects with known or suspected electrolyte abnormalities such as hypernatremia,
             hyponatremia, hyperphosphatemia, hypokalemia, hypocalcemia, dehydration, or those
             secondary to the use of diuretics or angiotensin converting enzyme (ACE) inhibitors.

          4. Subjects with clinically significant electrolyte abnormalities based on Visit 1
             laboratory results.

          5. Subjects with impaired consciousness that predisposes them to pulmonary aspiration.

          6. Subjects undergoing colonoscopy for foreign body removal and decompression.

          7. Subjects who are pregnant or lactating, or intending to become pregnant during the
             study.

          8. Subjects of childbearing potential who refuse a pregnancy test.

          9. Subjects allergic to any preparation components

         10. Subjects who, in the opinion of the Investigator, should not be included in the study
             for any reason, including inability to follow study procedures.

         11. Subjects who have participated in an investigational surgical, drug, or device study
             within the past 30 days.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John McGowan, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Braintree Laboratories, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of South Alabama</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36693</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jupiter Research</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Research Associates</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University Medical Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Island GI Research Group</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <lastchanged_date>October 15, 2010</lastchanged_date>
  <firstreceived_date>March 5, 2009</firstreceived_date>
  <firstreceived_results_date>September 3, 2010</firstreceived_results_date>
  <responsible_party>
    <name_title>John McGowan, Associate Director, Clinical Research</name_title>
    <organization>Braintree Laboratories, Inc.</organization>
  </responsible_party>
  <keyword>colonoscopy</keyword>
  <keyword>bowel preparation</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          <description>Active control - oral solution, 1 administration</description>
        </group>
        <group group_id="P2">
          <title>BLI800</title>
          <description>Investigational prep - oral solution, 1 administration</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
                <participants group_id="P2" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          <description>Active control - oral solution, 1 administration</description>
        </group>
        <group group_id="B2">
          <title>BLI800</title>
          <description>Investigational prep - oral solution, 1 administration</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="68"/>
                <measurement group_id="B2" value="68"/>
                <measurement group_id="B3" value="136"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="53"/>
                <measurement group_id="B2" value="50"/>
                <measurement group_id="B3" value="103"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="15"/>
                <measurement group_id="B2" value="18"/>
                <measurement group_id="B3" value="33"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="56.7" spread="11.0"/>
                <measurement group_id="B2" value="57.7" spread="10.8"/>
                <measurement group_id="B3" value="57.2" spread="10.8"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="31"/>
                <measurement group_id="B2" value="36"/>
                <measurement group_id="B3" value="67"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="37"/>
                <measurement group_id="B2" value="32"/>
                <measurement group_id="B3" value="69"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="68"/>
                <measurement group_id="B2" value="68"/>
                <measurement group_id="B3" value="136"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Efficacy: Percentage of Patients With Successful Preparations Based on a 4 Point Scale</title>
        <description>Blinded colonoscopists rated cleansing quality as either Excellent, Good, Fair or Poor. Scores of Excellent or Good were considered Successful preparations.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Efficacy: Percentage of Patients With Successful Preparations Based on a 4 Point Scale</title>
            <description>Blinded colonoscopists rated cleansing quality as either Excellent, Good, Fair or Poor. Scores of Excellent or Good were considered Successful preparations.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="89.6"/>
                  <measurement group_id="O2" value="98.4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.038</p_value>
            <method>Chi-squared</method>
            <param_type>Difference in success rates</param_type>
            <param_value>8.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.9</ci_lower_limit>
            <ci_upper_limit>16.8</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Stool - Cecum</title>
        <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Stool - Cecum</title>
            <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="91"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="22"/>
                  <measurement group_id="O2" value="9"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="5"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.010</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Stool - Ascending Colon</title>
        <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Stool - Ascending Colon</title>
            <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="69"/>
                  <measurement group_id="O2" value="91"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="24"/>
                  <measurement group_id="O2" value="9"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.020</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Stool - Transverse Colon</title>
        <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Stool - Transverse Colon</title>
            <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="82"/>
                  <measurement group_id="O2" value="92"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="9"/>
                  <measurement group_id="O2" value="8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.644</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Stool - Descending Colon</title>
        <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Stool - Descending Colon</title>
            <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="84"/>
                  <measurement group_id="O2" value="92"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="9"/>
                  <measurement group_id="O2" value="8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.763</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Stool - Sigmoid Colon/Rectum</title>
        <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Stool - Sigmoid Colon/Rectum</title>
            <description>The blinded colonoscopist rated residual stool in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="81"/>
                  <measurement group_id="O2" value="94"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="10"/>
                  <measurement group_id="O2" value="5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="5"/>
                  <measurement group_id="O2" value="1"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.173</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Fluid - Cecum</title>
        <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Fluid - Cecum</title>
            <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="15"/>
                  <measurement group_id="O2" value="43"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="63"/>
                  <measurement group_id="O2" value="44"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="15"/>
                  <measurement group_id="O2" value="13"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.004</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Fluid - Ascending Colon</title>
        <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Fluid - Ascending Colon</title>
            <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="36"/>
                  <measurement group_id="O2" value="64"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="43"/>
                  <measurement group_id="O2" value="36"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="15"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.001</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Fluid - Transverse Colon</title>
        <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Fluid - Transverse Colon</title>
            <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="49"/>
                  <measurement group_id="O2" value="68"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="30"/>
                  <measurement group_id="O2" value="32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="13"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="12"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.005</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Fluid - Descending Colon</title>
        <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Fluid - Descending Colon</title>
            <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="39"/>
                  <measurement group_id="O2" value="67"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="48"/>
                  <measurement group_id="O2" value="27"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="8"/>
                  <measurement group_id="O2" value="6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.013</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessment of Residual Fluid - Sigmoid Colon/Rectum</title>
        <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
        <time_frame>2 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Assessment of Residual Fluid - Sigmoid Colon/Rectum</title>
            <description>The blinded colonoscopist rated residual fluid in specific colon sections as Absent, Small, Moderate or Excess.</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Absent</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="48"/>
                  <measurement group_id="O2" value="64"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Small</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="42"/>
                  <measurement group_id="O2" value="32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Moderate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="8"/>
                  <measurement group_id="O2" value="5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Excess</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.283</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Symptom Scores</title>
        <description>Expected preparation related symptoms of Abdominal Cramping, Abdominal Bloating, Nausea and Overall discomfort were rated by each subject from 1 - 5 (1=none, 2=mild, 3=bothersome, 4=distressing, 5=severely distressing).</description>
        <time_frame>2 days</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Subject Symptom Scores</title>
            <description>Expected preparation related symptoms of Abdominal Cramping, Abdominal Bloating, Nausea and Overall discomfort were rated by each subject from 1 - 5 (1=none, 2=mild, 3=bothersome, 4=distressing, 5=severely distressing).</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Cramping</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.21" spread="0.45"/>
                  <measurement group_id="O2" value="1.33" spread="0.60"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Stomach bloating</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.62" spread="0.84"/>
                  <measurement group_id="O2" value="1.33" spread="0.54"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Nausea</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.82" spread="1.08"/>
                  <measurement group_id="O2" value="1.54" spread="0.71"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Overall discomfort</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.77" spread="0.94"/>
                  <measurement group_id="O2" value="1.65" spread="0.70"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Serum Chemistry (mg/dL)</title>
        <description>Mean changes from Baseline to Post-preparation for the following analytes will be compared between treatment groups: blood urea nitrogen, calcium, creatinine, phosphorus. Baseline lab samples were allowed to be drawn within 15 days of the post-preparation (Visit 2) lab draw.</description>
        <time_frame>up to 15 days</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Change in Serum Chemistry (mg/dL)</title>
            <description>Mean changes from Baseline to Post-preparation for the following analytes will be compared between treatment groups: blood urea nitrogen, calcium, creatinine, phosphorus. Baseline lab samples were allowed to be drawn within 15 days of the post-preparation (Visit 2) lab draw.</description>
            <units>mg/dL</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Blood Urea Nitrogen</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-3.95" spread="3.3"/>
                  <measurement group_id="O2" value="-3.78" spread="3.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Calcium</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-0.24" spread="0.45"/>
                  <measurement group_id="O2" value="-0.19" spread="0.49"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Creatinine</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.02" spread="0.09"/>
                  <measurement group_id="O2" value="0.01" spread="0.1"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Phosphorus</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-0.10" spread="0.53"/>
                  <measurement group_id="O2" value="-0.18" spread="0.99"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change in Serum Chemistry (mEq/L)</title>
        <description>Mean changes from Baseline to Post-preparation for the following analytes will be compared between treatment groups: bicarbonate, chloride, magnesium, potassium, sodium. Baseline lab samples were allowed to be drawn within 15 days of the post-preparation (Visit 2) lab draw.</description>
        <time_frame>up to 15 days</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
            <description>Active control - oral solution, 1 administration</description>
          </group>
          <group group_id="O2">
            <title>BLI800</title>
            <description>Investigational prep - oral solution, 1 administration</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="67"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Change in Serum Chemistry (mEq/L)</title>
            <description>Mean changes from Baseline to Post-preparation for the following analytes will be compared between treatment groups: bicarbonate, chloride, magnesium, potassium, sodium. Baseline lab samples were allowed to be drawn within 15 days of the post-preparation (Visit 2) lab draw.</description>
            <units>mEq/L</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Bicarbonate</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-0.81" spread="2.0"/>
                  <measurement group_id="O2" value="-1.76" spread="2.0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Chloride</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.66" spread="2.4"/>
                  <measurement group_id="O2" value="-0.37" spread="2.5"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Magnesium</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-0.04" spread="0.11"/>
                  <measurement group_id="O2" value="0.04" spread="0.13"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Potassium</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-0.16" spread="0.47"/>
                  <measurement group_id="O2" value="0.03" spread="0.64"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Sodium</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.36" spread="2.2"/>
                  <measurement group_id="O2" value="0.09" spread="2.4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Polyethylene Glycol 3350 Based Bowel Preparation</title>
          <description>Active control - oral solution, 1 administration</description>
        </group>
        <group group_id="E2">
          <title>BLI800</title>
          <description>Investigational prep - oral solution, 1 administration</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="67"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>nausea</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="67"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 360 days from the time submitted to the sponsor for review. The sponsor cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>As prespecified in the study protocol, expected prep related side effects (nausea, vomiting, cramping, bloating and overall discomfort) were only documented as AEs if patients rated them severely distressing on the study questionnaire.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>John McGowan</name_or_title>
      <organization>Braintree Laboratories, Inc.</organization>
      <phone>781-843-2202</phone>
      <email>jmcgowan@braintreelabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
